ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      58,340.24
      0.07%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Palisade Bio Inc (PALI)

      7. Palisade Bio Inc (PALI) News

      PALI

      Palisade Bio (PALI)

      Palisade Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PALI
      DateTimeSourceHeadlineSymbolCompany
      05/13/20228:40AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PALIPalisade Bio Inc
      05/10/20225:00PMGlobeNewswire Inc.Palisade Bio Announces Inducement Awards Under Inducement Plan for Key New HiresNASDAQ:PALIPalisade Bio Inc
      05/06/20225:24PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PALIPalisade Bio Inc
      05/06/20228:43AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PALIPalisade Bio Inc
      05/06/20228:30AMGlobeNewswire Inc.Palisade Bio Announces $2.0 Million Registered Direct OfferingNASDAQ:PALIPalisade Bio Inc
      05/05/20228:30AMGlobeNewswire Inc.Palisade Bio and Newsoara Receive NMPA Clearance to Commence Phase 3 Clinical Trial in China Evaluating LB1148 to Accelerate the Return of Bowel Function Following Abdominal SurgeryNASDAQ:PALIPalisade Bio Inc
      05/02/20224:40PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PALIPalisade Bio Inc
      05/02/20228:35AMGlobeNewswire Inc.Palisade Bio Provides Business Outlook and Highlights Expected Near-Term Pipeline AdvancementsNASDAQ:PALIPalisade Bio Inc
      04/29/20228:05AMGlobeNewswire Inc.Palisade Bio to Participate in the Virtual Investor Management and KOL Roundtable EventNASDAQ:PALIPalisade Bio Inc
      04/27/20226:08AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PALIPalisade Bio Inc
      04/27/20226:08AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PALIPalisade Bio Inc
      04/21/20225:13PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PALIPalisade Bio Inc
      04/20/20228:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PALIPalisade Bio Inc
      03/31/20228:32AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      03/29/20228:38AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      03/25/20228:02AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      03/24/20228:30AMGlobeNewswire Inc.Palisade Bio (Nasdaq: PALI) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group and Hosted by M-VestNASDAQ:PALIPalisade Bio Inc
      03/23/20221:35PMTipRanksMaxim Group Initiates a Buy Rating on Palisade Bio (PALI)NASDAQ:PALIPalisade Bio Inc
      03/22/20228:30AMGlobeNewswire Inc.Palisade Bio (Nasdaq: PALI) Receives FDA “Study May Proceed” Letter for Pivotal Phase 3 Clinical Trial Evaluating LB1148 to Accelerate the Return of Bowel Function Following Abdominal SurgeryNASDAQ:PALIPalisade Bio Inc
      03/18/20224:49PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PALIPalisade Bio Inc
      03/18/20224:46PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PALIPalisade Bio Inc
      03/18/20224:43PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PALIPalisade Bio Inc
      03/18/20228:30AMGlobeNewswire Inc.Palisade Bio (Nasdaq: PALI) Reports Year End 2021 Financial Results and Corporate UpdateNASDAQ:PALIPalisade Bio Inc
      03/17/20224:22PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:PALIPalisade Bio Inc
      03/16/202211:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PALIPalisade Bio Inc
      03/16/20228:00AMGlobeNewswire Inc.Palisade Bio (Nasdaq: PALI) Announces Analysis Demonstrating LB1148 Reduced the Extent and Severity of Post-Surgical Intraabdominal Adhesions by 93%NASDAQ:PALIPalisade Bio Inc
      03/09/20228:30AMGlobeNewswire Inc.Palisade Bio (Nasdaq: PALI) to Present New Clinical Data of LB1148 for Preventing Adhesions in Conjunction with Next Big Thing Session at Society of American Gastrointestinal and Endoscopic Surgeons 2022 Annual MeetingNASDAQ:PALIPalisade Bio Inc
      02/24/202211:50AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PALIPalisade Bio Inc
      02/24/20226:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PALIPalisade Bio Inc
      02/22/20225:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
       Showing the most relevant articles for your search:NASDAQ:PALI